| |
| |
|
| Insider
Information: |
Suri Anish |
| Relationship: |
PRESIDENT AND CSO |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
135,638 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$259,069 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
135,638 |
|
|
| Total
Value |
$259,069 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -32.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cue Biopharma, Inc. |
CUE |
PRESIDENT AND CSO |
2023-08-25 |
135,638 |
2018-12-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CUE |
Cue Biopharma, Inc. |
PRESIDENT AND CSO |
• – – |
2023-08-25 |
4 |
B |
$2.76 |
$11,040 |
D/D |
4,000 |
135,638 |
2.74 |
% |
|
| CUE |
Cue Biopharma, Inc. |
PRESIDENT AND CSO |
• – – |
2022-03-31 |
4 |
D |
$4.88 |
$34,492 |
D/D |
(7,068) |
103,638 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
PRESIDENT AND CSO |
• – – |
2022-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,668 |
110,706 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
President and CSO |
• – – |
2021-11-15 |
4 |
AS |
$18.05 |
$144,400 |
D/D |
(8,000) |
94,038 |
0 |
% |
|
| CUE |
Cue Biopharma, Inc. |
President and CSO |
• – – |
2021-11-15 |
4 |
OE |
$8.26 |
$66,080 |
D/D |
8,000 |
102,038 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
President and CSO |
• – – |
2021-11-11 |
4 |
OE |
$6.42 |
$128,400 |
D/D |
20,000 |
114,038 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
President and CSO |
• – – |
2021-11-11 |
4 |
AS |
$15.07 |
$301,354 |
D/D |
(20,000) |
94,038 |
0 |
% |
|
| CUE |
Cue Biopharma, Inc. |
PRESIDENT AND CSO |
• – – |
2021-10-06 |
4 |
D |
$12.97 |
$183,318 |
D/D |
(14,134) |
94,038 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
PRESIDENT AND CSO |
• – – |
2021-10-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,334 |
108,172 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
PRESIDENT AND CSO |
• – – |
2021-09-23 |
4 |
AS |
$15.23 |
$304,646 |
D/D |
(20,000) |
74,838 |
0 |
% |
|
| CUE |
Cue Biopharma, Inc. |
PRESIDENT AND CSO |
• – – |
2021-09-23 |
4 |
OE |
$6.42 |
$128,400 |
D/D |
20,000 |
94,838 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
President and CSO |
• – – |
2020-10-05 |
4 |
D |
$16.30 |
$159,740 |
D/D |
(9,800) |
58,091 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
President and CSO |
• – – |
2020-10-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,333 |
67,891 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
President and CSO |
• – – |
2020-08-05 |
4 |
AS |
$20.01 |
$16,008 |
D/D |
(800) |
34,558 |
0 |
% |
|
| CUE |
Cue Biopharma, Inc. |
President and CSO |
• – – |
2020-08-05 |
4 |
OE |
$6.42 |
$5,136 |
D/D |
800 |
35,358 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
President and CSO |
• – – |
2020-08-04 |
4 |
AS |
$20.14 |
$8,056 |
D/D |
(400) |
34,558 |
0 |
% |
|
| CUE |
Cue Biopharma, Inc. |
President and CSO |
• – – |
2020-08-04 |
4 |
OE |
$6.42 |
$2,568 |
D/D |
400 |
34,958 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
President and CSO |
• – – |
2020-08-03 |
4 |
OE |
$6.42 |
$40,916 |
D/D |
5,800 |
40,358 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
President and CSO |
• – – |
2020-08-03 |
4 |
AS |
$20.01 |
$116,058 |
D/D |
(5,800) |
34,558 |
0 |
% |
|
| CUE |
Cue Biopharma, Inc. |
President and CSO |
• – – |
2020-03-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,354) |
34,558 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
President and CSO |
• – – |
2020-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,666 |
39,912 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
President and CSO |
• – – |
2019-11-01 |
4 |
D |
$8.63 |
$104,311 |
D/D |
(12,087) |
23,246 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
President and CSO |
• – – |
2019-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,333 |
35,333 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
Chief Scientific Officer |
• – – |
2018-12-21 |
4 |
B |
$4.37 |
$8,740 |
D/D |
2,000 |
2,000 |
2.74 |
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
